Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemia Type II

Explore clinical trials studying Hyperlipoproteinemia Type II. Study availability and eligibility vary by location and protocol.

39 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipoproteinemia Type II trial results

Recruiting

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

NCT07491172

Conditions
Cardiovascular, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +20 more
Locations
  • Integrity Clinical Research Hialeah, Florida, United States
  • Jacksonville Center for Clinical Research Jacksonville, Florida, United States
  • Flourish Orlando Orlando, Florida, United States
  • United Medical Research Port Orange, Florida, United States
View all 19 locations
View Trial Details
Recruiting

Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

NCT07447648

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +16 more
Locations
  • Unité de Lipidologie et Prévention Cardiovasculaire, Centre de Compétence Dyslipidémies Rares (CEDRA), Service de Nutrition, Hôpital Pitié-Salpétriêre Paris, France
  • Dipartimento Scienze-Cardiovascolari, AO "Sant'Anna e San Sebastiano" di Caserta Caserta, Italy
  • U.O.C. di Medicina Interna, P.O. Nesima, ARNAS Garibaldi Catania, Italy
  • Nefrologia e Emodialisi, Centro Aterosclerosi e Dislipidemie, Ospedale Bassini, ASST Nord Milano Cinisello Balsamo, Italy
View all 13 locations
View Trial Details
Recruiting

HoFH, the International Clinical Collaborators Registry

NCT04815005

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +12 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Department of Vascular Medicine, Amsterdam UMC Amsterdam, Netherlands
  • Department of Medicine, Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, University of Cape Town Cape Town, South Africa
  • c. Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand Johannesburg, South Africa
View Trial Details
Active, not recruiting

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

NCT07037771

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Research Site 7 Park Ridge, Illinois, United States
  • Research Site 2 New York, United States
  • Research Site 1 Cincinnati, Ohio, United States
  • Research Site 14 Pittsburgh, Pennsylvania, United States
View all 43 locations
View Trial Details
Active, not recruiting

Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

NCT06832371

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +18 more
Locations
  • CHRU Lille - Centre Hospitalier Universitaire de Lille Lille, France
  • Centre Hospitalier Universitaire de Lyon (CHU Lyon) Lyon, France
  • Hôpital de la Conception - Assistance Publique Hôpitaux de Marseille (AP-HM) Marseille, France
  • Hôpital La Pitié Salpêtrière - Groupe Hospitalier "La Pitié Salpêtrière - Charles Foix" Paris, France
View all 30 locations
View Trial Details

Related conditions